ContactLog in

Obelisk Training Webinar “Recommendations: A Guide to Monogenic Obesity”

Terug

Publicatiedatum: 09/03/2026

Locatie:

Online Webinar

Datum:

26/03/2026

26/03/2026

Tijd:

11:00

12:30

Recommendations: A guide to monogenic obesity.
This is an online session for healthcare professionals who support children and families where obesity is a presenting or co-existing concern.  This would include communityprimary and secondary care workers such as GPs, dietitianshealth visitorsschool nursesweight management teamspaediatricians and allied health professionals.

The webinar will explain:

  • What monogenic obesity is
  • Why recognising monogenic obesity is important within healthcare,
  • Actionable recommendations and the ethical, legal and social implications (ELSI) related to this topic.

The presentations will be followed by an informal discussion and question and answer session, facilitated by ECOG’s Pietro Urgera.

The sessions will be led by Obelisk co-cordinators Professor Philippe Froguel and Dr. Amélie Bonnefond.

Professor Philippe Froguel: Philippe is a renowned geneticist known for his contributions to the field of diabetes research. He has made significant discoveries in the genetic basis of obesity and type 2 diabetes. Philippe has identified several gene variants associated with these conditions, shedding light on their underlying mechanisms. He has published extensively, received numerous awards, and held prestigious academic positions. His research has paved the way for personalized medicine approaches in diabetes and obesity, offering insights into prevention, diagnosis, and treatment strategies.

Dr Amélie Bonnefond: Her scientific career has been focused on the dissection of the genetic aetiologies of type 2 diabetes and obesity to elucidate their pathophysiology towards a better stratification of the patients and a putative identification of new drug targets. She is Director of Research at Inserm and heads a team tackling Metabolic functional (epi)genomics and their abnormalities in type 2 diabetes and related disorders.

More information and registration you will find on the Obelisk website